Page last updated: 2024-09-03

p(1),p(5)-di(adenosine-5'-)pentaphosphate and caffeine

p(1),p(5)-di(adenosine-5'-)pentaphosphate has been researched along with caffeine in 2 studies

Compound Research Comparison

Studies
(p(1),p(5)-di(adenosine-5'-)pentaphosphate)
Trials
(p(1),p(5)-di(adenosine-5'-)pentaphosphate)
Recent Studies (post-2010)
(p(1),p(5)-di(adenosine-5'-)pentaphosphate)
Studies
(caffeine)
Trials
(caffeine)
Recent Studies (post-2010) (caffeine)
21522625,5012,3936,825

Protein Interaction Comparison

ProteinTaxonomyp(1),p(5)-di(adenosine-5'-)pentaphosphate (IC50)caffeine (IC50)
AcetylcholinesteraseHomo sapiens (human)7.25

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanaide, H; Kawasaki, J; Kobayashi, S; Nishimura, J; Sumiyoshi, R; Takahashi, S1
Dolhun, B; Geiger, JD; Haughey, NJ; Holden, CP; Nath, A; Shepel, PN1

Other Studies

2 other study(ies) available for p(1),p(5)-di(adenosine-5'-)pentaphosphate and caffeine

ArticleYear
Diadenosine polyphosphates directly relax porcine coronary arterial smooth muscle.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 283, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Caffeine; Calcium; Coronary Vessels; Cyclic AMP; Cyclic GMP; Dinucleoside Phosphates; Histamine; In Vitro Techniques; Muscle, Smooth, Vascular; Potassium Channel Blockers; Swine; Vasodilation

1997
Diadenosine pentaphosphate increases levels of intracellular calcium in astrocytes by a mechanism involving release from caffeine/ryanodine- and IP3-sensitive stores.
    Journal of neuroscience research, 2000, Jan-15, Volume: 59, Issue:2

    Topics: Adenosine Triphosphate; Astrocytes; Bradykinin; Caffeine; Calcium; Central Nervous System Stimulants; Dinucleoside Phosphates; Extracellular Space; Fetus; Humans; Inositol 1,4,5-Trisphosphate; Macrocyclic Compounds; Oxazoles; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2Y1; Ryanodine; Ryanodine Receptor Calcium Release Channel; Vasoconstrictor Agents

2000